Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
09/11/2013 | CN103285163A Formula of traditional Chinese medicine for treating diabetes with other complications |
09/11/2013 | CN103285160A Novel method for reducing blood pressure by dracocephalum moldavuca linn, medlar and mother chrysanthemum engendering liquid and allaying thirst |
09/11/2013 | CN103285154A Traditional Chinese medicine preparation for treating haemorrhoids |
09/11/2013 | CN103285153A Internally and externally applied medicines for treating haemorrhoids and method |
09/11/2013 | CN103285148A Chinese medicament for treating cerebral thrombosis |
09/11/2013 | CN103285142A Traditional Chinese medicine formula for improving brain functions and treating encephalatrophy |
09/11/2013 | CN103285115A Preparation method of active components of compound traditional Chinese medicine for treatment of cardiovascular and cerebrovascular ischemic diseases |
09/11/2013 | CN103285104A Traditional Chinese medicine injection for repairing myocardial injury |
09/11/2013 | CN103285102A Chinese herbal medicine beer hot spring soaking solution and preparation method thereof |
09/11/2013 | CN103285096A Applications of Shenkang injection in preparation of medicine used for treatment of hypertensive nephropathy |
09/11/2013 | CN103285090A Traditional Chinese medicine rhizoma corydalis pellet pseudo-ginseng powder for treatment of coronary atherosclerotic cardiopathy |
09/11/2013 | CN103285072A Hyperoside-containing extract and medical application thereof |
09/11/2013 | CN103285059A Medicament for treating haemorrhoids |
09/11/2013 | CN103285056A Traditional Chinese medicine preparation for preventing and curing cardiovascular diseases and preparation method thereof |
09/11/2013 | CN103285051A Composite preparation of ginkgo extract and vinpocetine and application thereof |
09/11/2013 | CN103285050A Preparation method for ginkgo biloba armillaria oral solid preparation |
09/11/2013 | CN103285031A Application of depolymerized holothurian glycosaminolycan in preparation of medicine for preventing and treating thromboembolism diseases |
09/11/2013 | CN103285028A Composite antibacterial agent of chitosan and organosilicone quaternary ammonium salt and preparation method of composite antibacterial agent |
09/11/2013 | CN103285020A Application of glycyrrhizic acid in preparation of sunitinib malate cardiotoxicity reduction drug |
09/11/2013 | CN103285019A Application of anemonin A in preparing medicine for treating neovascular eye diseases |
09/11/2013 | CN103285017A Compound isosorbide mononitrate aspirin sustained-release capsule preparation and preparation method |
09/11/2013 | CN103285014A Amlodipine mesylate-containing composition for high blood pressure treatment |
09/11/2013 | CN103285006A Application of Myriberine A in preparation of drug for treatment or prevention of acute heart failure |
09/11/2013 | CN103284998A Protoberberine quaternary ammonium base composition and use thereof |
09/11/2013 | CN103284989A Application of tanshinol derivatives in preparation of drug for preventing cardiovascular-related diseases |
09/11/2013 | CN103284987A Application of propargyl cysteine and analogues thereof in preparation of medicaments for preventing and treating diseases related to cardiovascular system inflammation |
09/11/2013 | CN103284984A Process for the production of 2-[4-(3- and 2-flu0r0benzyl0xy)benzylamin0]propanamides |
09/11/2013 | CN103284979A Use of gamma-elemene and derivatives thereof in preventing atherosclerosis |
09/11/2013 | CN103284978A Use of beta-elemene and derivatives thereof in preventing atherosclerosis |
09/11/2013 | CN103284972A Prescription of clopidogrel bisulfate tablet and preparation process thereof |
09/11/2013 | CN103284970A Sarpogrelate hydrochloride sustained release preparation and preparation method thereof |
09/11/2013 | CN103284966A 坎地沙坦酯分散片 Candesartan cilexetil tablet |
09/11/2013 | CN103284948A Preparation and application of polymer composition loaded with sirolimus compound or its derivative |
09/11/2013 | CN103284943A Novel method for preparing penehyclidine hydrochloride injection |
09/11/2013 | CN103284152A Dietary fiber extracted from Chinese yew, extraction method and use |
09/11/2013 | CN102920826B Traditional Chinese medicine composition for treating haemorrhoids |
09/11/2013 | CN102824612B Traditional Chinese medicine for treating dilated cardiomyopathy |
09/11/2013 | CN102824594B Traditional Chinese medicine for treating vital myocarditis |
09/11/2013 | CN102823792B Soft propolis astragalus mongholicus capsule and preparation method thereof |
09/11/2013 | CN102754830B Giant salamander health-care food for patient with hypertension |
09/11/2013 | CN102727723B Traditional Chinese herbal rectal administration capsule for treating hemorrhoids |
09/11/2013 | CN102697954B White paeony root Chinese herbal preparation for treating headache and preparation method thereof |
09/11/2013 | CN102671213B Scutellarin prodrug and preparation method thereof |
09/11/2013 | CN102670537B Trimetazidine dihydrochloride sustained release tablet and preparation method thereof |
09/11/2013 | CN102670441B Traditional Chinese medicine toilet soap for preventing and treating piles |
09/11/2013 | CN102614463B Patch for treatment of arterial embolism of transplanted kidney |
09/11/2013 | CN102600143B Vinpocetine medicament composition and preparation method thereof |
09/11/2013 | CN102580044B Black clay paste product for treating phlebeurysma and production method thereof |
09/11/2013 | CN102579882B Dropping pills for preventing and curing hypertension and hyperlipidemia and preparation method |
09/11/2013 | CN102579864B Traditional Chinese medicine for treating hemorrhoids |
09/11/2013 | CN102579610B Chinese medicinal composition for treating cerebral hemorrhage and preparation method thereof |
09/11/2013 | CN102526343B Traditional Chinese medicine composition for tonifying qi, activating blood and dredging collaterals |
09/11/2013 | CN102475766B Drug composition for treating heart failure, preparation method and application of drug composition |
09/11/2013 | CN102462753B Traditional Chinese medicine composition capable of treating cervical vertigo and preparation method thereof |
09/11/2013 | CN102366518B Method for ultrasonic assisted aqueous two-phase extraction of total dioscin |
09/11/2013 | CN102351874B New erigeroster compound with medicinal activity |
09/11/2013 | CN102342921B Pharmaceutical composition of prasugrel hydrobromide acetate compound |
09/11/2013 | CN102277400B Extract containing beta-1,3-D-glucan and use thereof |
09/11/2013 | CN102216318B 抗氧化剂 Antioxidants |
09/11/2013 | CN102093460B Triterpenoid saponin compound as well as synthesis method and application of triterpenoid saponin |
09/11/2013 | CN102086211B Aromatic heterocyclic compounds serving as protein kinase inhibitor |
09/11/2013 | CN102066397B Compounds including an anti-inflammatory pharmacore and methods of use |
09/11/2013 | CN101831435B Preparation and application of IL-15 isoform protein of mice |
09/11/2013 | CN101616909B Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase |
09/11/2013 | CN101611028B Substituted oxindole derivatives and their use as vasopressin receptor ligands |
09/11/2013 | CN101437521B Use of 3,5-seco-4-norcholestane derivatives for obtaining a cytoprotective medicament |
09/10/2013 | US8530505 Substituted oxazolidinones and their use in the field of blood coagulation |
09/10/2013 | US8530448 Compounds and methods for inhibiting selectin-mediated function |
09/10/2013 | US8530447 Dietary fiber formulation and method of administration |
09/10/2013 | US8530441 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
09/10/2013 | US8530438 Vivo production of small interfering RNAs that mediate gene silencing |
09/10/2013 | US8530407 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
09/10/2013 | US8530173 Methods for treatment of cardiovascular disease |
09/10/2013 | US8529871 in a patient receiving high dose radioactive iodine for treatment of cancer; administering to the eyes of said patient an effective amount of perchlorate anion |
09/10/2013 | CA2758894C Novel thyroid hormone .beta. receptor agonist |
09/10/2013 | CA2721670C 3-phenylpyrazolo[5,1-b]thiazole compound |
09/10/2013 | CA2619386C Method of reducing the risk of adverse cardiovascular (cv) events associated with the administration of pharmaceutical agents which favor cv events |
09/10/2013 | CA2587444C Guanidine derivatives as inhibitors of ddah |
09/10/2013 | CA2557758C Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
09/06/2013 | WO2013130577A2 Compositions and methods for the treatment of migraine |
09/06/2013 | WO2013130499A1 Compositions and methods for cxcr4 signaling and umbilical cord blood stem cell engraftment |
09/06/2013 | WO2013130411A1 Salts of potassium atp channel openers and uses thereof |
09/06/2013 | WO2013128378A1 Phenyl alkanoic acid derivatives as gpr agonists |
09/06/2013 | WO2013128037A1 Prodrugs of vitamine k |
09/06/2013 | WO2013128029A1 Pharmaceutically active pyrazolo-triazine derivatives |
09/06/2013 | WO2013128028A1 Pyrazolo - triazine derivatives as selective cyclin- dependent kinase inhinitors |
09/06/2013 | WO2013127268A1 Amido-benzyl sulfone and sulfonamide derivatives |
09/06/2013 | WO2013127267A1 Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives |
09/05/2013 | US20130230522 Complement Pathway Inhibitors Binding To C5 and C5A Without Preventing The Formation of C5B |
09/05/2013 | US20130230501 Cycloalkyl-Substituted Imidazole Derivative |
09/04/2013 | EP2634190A1 Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors |
09/04/2013 | EP2634189A1 Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhibitors |
09/04/2013 | EP2632950A1 Method for preventing myocardial infarction-related complications |
09/04/2013 | EP2632937A1 Peptide |
09/04/2013 | EP2632919A2 Pyrazole compounds |
09/04/2013 | EP2632906A1 Oxazoline and isoxazoline derivatives as crac modulators |
09/04/2013 | EP2632903A2 Metalloenzyme inhibitor compounds |
09/04/2013 | EP2632551A1 Soluble guanylate cyclase activators |
09/04/2013 | EP2632477A2 Methods of treatment with natriuretic peptides |